Big Pharma trio backs cancer startup; AB jumps on ALS data; Shire founder oversees AIM listing

Nick Paul Taylor In this week's EuroBiotech Report, Metabomed celebrated adding Pfizer to a list of investors that already featured the VC units of Merck KGaA and Boehringer Ingelheim. ...

Accelerator’s second NYC biotech startup sets out with $17M and some Gates-backed science

Damian Garde Accelerator, among the financiers looking to kick-start a fledgling biotech hub in New York City, launched its second local project in the form of Lodo Therapeutics, a ...

Wellcome invests $38M in another gene therapy startup, targeting hemophilia

Damian Garde The Wellcome Trust's investment arm is putting up £25 million ($ 38 million) to launch a new company developing a potential one-time treatment for hemophilia ...

Sofinnova Partners launches a €300M biotech startup fund with a transatlantic focus

John Carroll PARIS–Sofinnova Partners has reloaded its cash reserves and started to build the next wave of 15 to 20 biotechs for its portfolio. The venture group has wrapped a ...

Startup raises $15M to turn an old diabetes drug into a potent cancer killer

Damian Garde A group of scientists at UCLA have cooked up some compounds that could harness the cancer-fighting properties of metformin while avoiding the biological hurdles that have ...

Lilly backs a $25M round for anti-inflammatory startup Symic

Damian Garde San Francisco's Symic raised $ 25 million to fund its work on a pair of anti-inflammatory medicines targeting the extracellular matrix, recruiting Eli Lilly to lead ...

A biotech startup grows out of GlaxoSmithKline’s discarded NC R&D

Damian Garde GlaxoSmithKline is laying off nearly 1,000 employees in North Carolina in an effort to trim its R&D costs, cutting deep into the biotech ecosystem in Research Triangle ...

Cannabis patch startup pulls off a $42M IPO to fund drugs for epilepsy, pain

Damian Garde Pennsylvania drugmaker Zynerba Pharmaceuticals is making its way to Wall Street with some cannabis-derived treatments for central nervous system disorders, raising $ 42 ...

Atlas Venture unveils a $280M pure play biotech startup fund

John Carroll Squarely focused on seeding and nurturing biotech startups and armed with some of the best relationships in the business, Atlas Venture is unveiling a new $ 280 million ...

Novartis makes concerted push into Israeli biotech startup scene

Nick Paul Taylor Over the past year, Novartis has struck a pair of deals in Israel, snagging an option to buy Gamida Cell and a stake in BioLineRx. FierceBiotech News

Intrexon takes a $60M flyer on a synthetic biology startup

Damian Garde Billionaire R.J. Kirk's Intrexon has signed a $ 60 million deal to acquire ActoGeniX, a Belgian biotech at work on oral drugs designed to generate therapeutic proteins ...

Lux Capital raises $350M to expand its startup portfolio

Damian Garde Lux Capital, a New York venture investor, put together a $ 350 million fourth fund, cash that will help bankroll startups in energy, technology and biotech. FierceBiotech ...
Page 1 of 41234
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS